MPE to hold the “EHA 2016 Highlights in myeloma” webinar on 14th JulyConferences, MPE, MyelomaJune 24, 2016
MPE encourages EMA to review its negative recommendation for ixazomibAccess, MPE, MyelomaAugust 16, 2016
EMA reconsiders and gives its positive opinion for the approval of ixazomibAccess, MyelomaSeptember 17, 2016
Myeloma patient survey to inform development of personalised medicine toolMPE, Myeloma, Patient evidenceMarch 26, 2018
Official launch of EuroBloodNet, the European Reference Network on rare haematological diseasesAL amyloidosis, MyelomaMarch 21, 2017
Mayo Clinic researchers identify therapy that shrinks tumors in patients with myelomaMyelomaMarch 13, 2017
Myeloma Patients Europe (MPE) relaunches Myeloma Access Atlas platformAccess, MPE, MyelomaOctober 19, 2021
The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myelomaAccess, MyelomaAugust 30, 2022
